Biofrontera

(NASDAQ) BFRI

Current Price$1.15

Market Cap$13.40M

Since IPO (2021)-99%

5 YearN/A

1 Year+58%

1 Month+20%

Biofrontera Financials at a Glance

Market Cap

$13.40M

Revenue (TTM)

$41.71M

Net Income (TTM)

$10.54M

EPS (TTM)

$-1.18

P/E Ratio

-0.98

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$1.15

Volume

2,509

Open

$1.14

Price

$1.15

Volume

2,509

Open

$1.14

Previous Close

$1.15

Daily Range

$1.14 - $1.15

52-Week Range

$0.54 - $1.19

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$1.15

Volume

2,509

Open

$1.14

Previous Close

$1.15

Daily Range

$1.14 - $1.15

52-Week Range

$0.54 - $1.19

BFRI News

Biofrontera Q2 Revenue Jumps 15%

Motley Fool Markets TeamAug 14, 2025

Biofrontera Revenue Jumps 15% in Q2

Motley Fool Markets TeamAug 13, 2025

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Biofrontera

Industry

Pharmaceuticals

Sector

Health Care

Employees

CEO

Hermann Lübbert, PhD

Website

www.biofrontera-us.com

Headquarters

Woburn, MA 01801, US

BFRI Financials

Key Financial Metrics (TTM)

Gross Margin

76%

Operating Margin

-27%

Net Income Margin

-25%

Return on Equity

-141%

Return on Capital

-68%

Return on Assets

-37%

Earnings Yield

-1.02%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$13.40M

Shares Outstanding

11.65M

Volume

2.51K

Avg. Volume

371.26K

Financials (TTM)

Gross Profit

$31.59M

Operating Income

$11.35M

EBITDA

$10.48M

Operating Cash Flow

$13.36M

Capital Expenditure

$2.00K

Free Cash Flow

$13.36M

Cash & ST Invst.

$6.39M

Total Debt

$6.16M

Biofrontera Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

$17.10M

+36.2%

Gross Profit

$14.37M

+97.1%

Gross Margin

84.01%

N/A

Market Cap

$13.40M

N/A

Market Cap/Employee

$145.60K

N/A

Employees

N/A

Net Income

$5.64M

+504.0%

EBITDA

$4.78M

+525.5%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Net Cash

$231.00K

-76.7%

Accounts Receivable

$7.29M

+37.2%

Inventory

$1.43M

-78.5%

Long Term Debt

$5.83M

+33.3%

Short Term Debt

$332.00K

-39.4%

Return on Assets

-36.89%

N/A

Return on Invested Capital

-68.07%

N/A

Free Cash Flow

$2.38M

-133.3%

Operating Cash Flow

$2.38M

-133.6%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

COCPCocrystal Pharma, Inc.

COCPCocrystal Pharma, Inc.$1.44+3.60%

IMNNImunon, Inc.

IMNNImunon, Inc.$2.72-0.37%

AYTUAytu BioPharma, Inc.

AYTUAytu BioPharma, Inc.$2.50+1.21%

TRIBTrinity Biotech plc

TRIBTrinity Biotech plc$0.61+2.52%

EVGNEvogene Ltd.

EVGNEvogene Ltd.$0.75-3.75%

SBFMSunshine Biopharma, Inc.

SBFMSunshine Biopharma, Inc.$1.05-2.77%

GELSGelteq Limited Ordinary Shares

GELSGelteq Limited Ordinary Shares$0.47+0.86%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

RXTRackspace Technology

RXTRackspace Technology$5.49+0.56%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$15.62+0.08%

IRENIren

IRENIren$61.20+0.08%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$76.28+0.07%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$42.57-0.07%

AALAmerican Airlines Group

AALAmerican Airlines Group$13.35+0.01%

BBBlackBerry

BBBlackBerry$6.37+0.04%

Questions About BFRI

What is the current price of Biofrontera?

Biofrontera is trading at $1.15 per share.

What is the 52-week range for Biofrontera?

Over the past 52 weeks, Biofrontera has traded between $0.54 and $1.19.

How much debt does Biofrontera have?

As of the most recent reporting period, Biofrontera reported total debt of $6.16M.

How much cash does Biofrontera have on hand?

Biofrontera reported $6.39M in cash and cash equivalents in its most recent financial results.

What is Biofrontera’s dividend yield?

Biofrontera does not currently have a dividend yield.

Biofrontera

Biofrontera Financials at a Glance

BFRI News

Biofrontera Q2 Revenue Jumps 15%

Biofrontera Revenue Jumps 15% in Q2

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Biofrontera

BFRI Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Biofrontera Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About BFRI

What is the current price of Biofrontera?

What is the 52-week range for Biofrontera?

How much debt does Biofrontera have?

How much cash does Biofrontera have on hand?

What is Biofrontera’s dividend yield?

Premium Investing Services